[ad_1]
A chemical in curry powder could fight cancer, according to research.
Scientists suggest that curcumin, a chemical in turmeric that gives curry powder its yellow color, could slow the growth of tumors in bad and blood cancers. ]
It does this by making cancer cells less able to destroy or destroy other cells.
Although researchers at the University of California say that eating spices or supplements does not fight cancer, the discovery could
And Curcumin, that the l? once thought to be able to fight cancer, can be 500 times stronger than previously thought.
Lab tests are found when combined with a drug commonly used for a specific type of blood cancer, curcumin has worked better while reducing side effects.
Researchers say their results, from experiments on mice, are "unexpected" and they now hope to develop a targeted drug against cancer using curcumin.
Curcumin could be used to fight cancer because in the bloodstream it binds to a specific type of enzyme called DYRK2 and when both are connected, the cells can not reproduce.
A hallmark of cancer is its ability to grow rapidly and uncontrollably, but this could be slowed down by curcumin, say the researchers.
On a study in mice using curcumin significantly reduced the size of tumors and stopped spreading as much.
Cherav Banerjee, researcher, said, "In general, curcumin is expelled from the body fairly quickly. For curcumin to be an effective drug, it must be modified to enter the bloodstream and stay in the body long enough to target cancer.
"Due to various chemical disadvantages, curcumin alone"
The study was performed in mice with multiple myeloma – a cancer of white blood cells – or a triple negative bad cancer, accounting for about 15% of cases.In the past, it was thought that curcumin fought cancer cells by binding to different enzymes, but when it does not occur attached to DYRK2, it is 500 times more effective.
Co-author Jack Dixon added: "Our findings reveal an unexpected role of curcumin [and] may offer new opportunities for the treatment of cancer triple negative bad and treatment of multiple myeloma difficult to treat
"Our main goal is to develop a chemical compound that can target DYRK2 in patients
The combination of curcumin with an approved drug kills da vantage of cancer cells.
Researchers linked curcumin to cafrilzomib, a drug approved by the US Food and Drug Administration for patients with multiple myeloma.
The combination of both caused the death of more cancer cells and fewer normal cells, which means that curcumin could someday lead to a more potent drug with fewer side effects
]
[ad_2]
Source link
